FUNDING-FDA -- BROAD AGENCY ANNOUNCEMENT - FDABAA-18-00123N (PRESOL) (FBO007U)

 

Agency

 

Food and Drug Administration

 

Description

 

The Food and Drug Administration (FDA) has issued a solicitation for research and development to support regulatory science and innovation. FDA anticipates that research and development activities awarded under this Broad Agency Announcement (BAA) will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation. This announcement will remain open until further notice. The purpose of this BAA is to solicit proposals that focus on one or more of the following areas of interest as listed here and further described in Part I of this announcement.

 

1. Modernize Toxicology to Enhance Product Safety

2. Stimulate Innovation in Clinical Evaluations and Personalized Medicine to Improve Product Development and Patient Outcomes

3. Support New Approaches to Improve Product Manufacturing and Quality

4. Ensure FDA Readiness to Evaluate Innovative Emerging Technologies

5. Harness Diverse Data through Information Sciences to Improve Health Outcomes

6. Implement a New Prevention-Focused Food Safety System to Protect Public Health

7. Facilitate Development of Medical Countermeasures to Protect Against Threats to U.S. and Global Health and Security

8. Strengthening Social and Behavioral Science at FDA by Enhancing Audience Understanding

9. Strengthening the Global Product Safety Net

 

Announcement Number:

 

FDABAA-18-00123N

 

Link to Full Announcement

 

https://www.fbo.gov/?s=opportunity&mode=form&id=4bcd5f15e01696059e3f3d83d56690b8&tab=core&_cview=0

 

Contact Information

 

Robert Maydwell

301-348-1814

Robert.Maydwell@fda.hhs.gov